# The APOL1 variant p.N264K is predicted to block ion flow by occluding a pore at the cell surface

**Authors:** Verena Höffken, Lara Console, Niklas Nelde, Hermann Pavenstädt, Cesare Indiveri, Thomas Weide

PMC · DOI: 10.26508/lsa.202503570 · 2026-03-10

## TL;DR

A new APOL1 variant, p.N264K, is found to prevent kidney toxicity by blocking ion flow through a pore at the cell surface.

## Contribution

This study provides the first mechanistic explanation for the protective effect of the APOL1 M1-G2 variant against kidney toxicity.

## Key findings

- The p.N264K variant physically blocks ion flux by occluding a pore at the cell surface.
- Both G2 and M1-G2 variants have similar intracellular localization and surface expression.
- Molecular dynamics suggest lysine at position 264 in M1-G2 prevents ion pore activity.

## Abstract

Based on a combination of in silico and cell biological analyses, this study suggests that the APOL1 variant p.N264K (M1) may prevent G2-mediated kidney toxicity by physically blocking ion flux.

The APOL1 gene variants G1 and G2 are associated with an increased risk of APOL1-mediated kidney disease. A recently identified variant, p.N264K (M1), mitigates this risk of renal damage by abolishing APOL1-G2’s associated cytotoxicity. However, the molecular and structural basis of this protective effect remains incompletely understood. In this study, we first show that both the cytotoxic G2 and the nontoxic M1-G2 exhibit similar intracellular localization, surface expression, and turnover kinetics. Moreover, N-glycosylation assays indicated no differences in topology, and 3D models demonstrated that both cytotoxic G2 and nontoxic APOL1 M1-G2 span the membrane four times, forming a potential ion channel. Interestingly, molecular dynamics analyses of a computational APOL1 3D model further revealed that in case of M1, the lysine at position 264 occludes this channel, thereby preventing ion pore activity of APOL1. These findings provide, for the first time, a mechanistic explanation for the nontoxic behavior of the APOL1 M1-G2 variant. Additional 3D analyses suggest that the C-terminal region may contribute to APOL1 multimerization, potentially influencing ion flux and cytotoxicity.

## Linked entities

- **Genes:** APOL1 (apolipoprotein L1) [NCBI Gene 8542]
- **Diseases:** kidney disease (MONDO:0001343)

## Full-text entities

- **Genes:** ACTN4 (actinin alpha 4) [NCBI Gene 81] {aka ACTININ-4, FSGS, FSGS1}, APOL1 (apolipoprotein L1) [NCBI Gene 8542] {aka APO-L, APOL, APOL-I, FSGS4}
- **Diseases:** Infection (MESH:D007239), PM (MESH:C536778), cytotoxic (MESH:D064420), protozoal infections (MESH:D020808), AMKDs (MESH:D007674), African sleeping sickness (MESH:D014353)
- **Chemicals:** POPC (MESH:C065191), bromophenol blue (MESH:D001978), NP-40 (MESH:C010615), Lipofectamine 2000 (MESH:C086724), streptomycin (MESH:D013307), fatty acids (MESH:D005227), methanol (MESH:D000432), NaCl (MESH:D012965), A-21244 (-), Dox (MESH:D004318), penicillin (MESH:D010406), puromycin (MESH:D011691), glycerin (MESH:D005990), Na+ (MESH:D012964), AF647 (MESH:C569686), K+ (MESH:D011188), PVDF (MESH:C024865), SDS (MESH:D012967), M1 (MESH:C400939), KCl (MESH:D011189), PBS (MESH:D007854), myristic acid (MESH:D019814), CaCl2 (MESH:D002122), calcium (MESH:D002118), argon (MESH:D001128), glucose (MESH:D005947), DMSO (MESH:D004121), DAPI (MESH:C007293), cholesterol (MESH:D002784), CO2 (MESH:D002245), H2O (MESH:D014867), polybrene (MESH:D006583), MG-132 (MESH:C072553)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G2) in the C, S342G, K264, T1010L, asparagine by lysine, P0704L, I384M, S15145S
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), pInducer21 — Homo sapiens (Human), Embryonic stem cell (CVCL_VF83)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976425/full.md

---
Source: https://tomesphere.com/paper/PMC12976425